CIC
BIIB icon

Chilton Investment Company’s Biogen BIIB Stock Holding History

Chilton Investment Company’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,872
Closed -$443K – 111
2019
Q1 		$443K Buy
+1,872
New +$589K 0.02% 99
2016
Q3 		– Sell
-123,200
Closed -$29.8M – 121
2016
Q2 		$29.8M Buy
123,200
+50,365
+69% +$13.3M 1.06% 29
2016
Q1 		$19M Buy
+72,835
New +$19.2M 0.7% 29

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Chilton Investment Company's BIIB Position: Q2 2019 in Review

Chilton Investment Company sold out of Biogen (BIIB) in Q2 2019, closing a stake of 1,872 shares — an estimated $443K sold.

Chilton Investment Company first reported a position in BIIB in Q1 2016 and held it in 3 quarters. The position peaked at $29.8M in Q2 2016. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Chilton Investment Company reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Chilton Investment Company sold 1,872 Biogen shares in Q2 2019, an estimated $443K.
  • Chilton Investment Company first reported a position in Biogen in Q1 2016 and held it in 3 quarters.
  • Chilton Investment Company's Biogen position peaked at $29.8M in Q2 2016.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Chilton Investment Company's 13F filing for Q2 2019, filed 12 Aug 2019.